deltatrials
Active Not Recruiting PHASE1 INTERVENTIONAL 1-arm NCT03264664

Study of E7386 in Participants With Selected Advanced Neoplasms

An Open-Label, Multicenter, Phase 1 Study of E7386 in Subjects With Selected Advanced Neoplasms

Sponsor: Eisai Inc.

Conditions Advanced Neoplasms
Interventions E7386
Updated 21 times since 2017 Last updated: Mar 4, 2026 Started: Jul 27, 2017 Primary completion: Mar 31, 2027 Completion: Mar 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Advanced Neoplasms, this trial is ongoing. The trial is conducted by Eisai Inc. and has accumulated 21 data snapshots since 2017. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Sep 2017 – ~Jun 2018 · 9 months · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Feb 2019 · 5 months · monthly snapshot~Feb 2019 – ~Jun 2019 · 4 months · monthly snapshot~Jun 2019 – ~Nov 2019 · 5 months · monthly snapshot~Nov 2019 – ~Apr 2020 · 5 months · monthly snapshot~Apr 2020 – ~May 2020 · 30 days · monthly snapshot~May 2020 – ~Nov 2020 · 6 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Nov 2021 · 10 months · monthly snapshot~Nov 2021 – ~Oct 2022 · 11 months · monthly snapshot~Oct 2022 – ~Dec 2022 · 2 months · monthly snapshot~Dec 2022 – ~Mar 2023 · 3 months · monthly snapshot~Mar 2023 – ~Jul 2023 · 4 months · monthly snapshot~Jul 2023 – ~Nov 2023 · 4 months · monthly snapshot~Nov 2023 – ~Dec 2023 · 30 days · monthly snapshot~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jul 2025 · 10 months · monthly snapshot~Jul 2025 – ~Mar 2026 · 8 months · monthly snapshot~Mar 2026 – present · 5 months · monthly snapshot

Change History

21 versions recorded

  1. Mar 2026 — Present [monthly]

    Active Not Recruiting PHASE1

  2. Jul 2025 — Mar 2026 [monthly]

    Active Not Recruiting PHASE1

  3. Sep 2024 — Jul 2025 [monthly]

    Active Not Recruiting PHASE1

  4. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE1

    Status: Recruiting → Active Not Recruiting

  5. Dec 2023 — Jul 2024 [monthly]

    Recruiting PHASE1

▶ Show 16 earlier versions

  1. Nov 2023 — Dec 2023 [monthly]

    Recruiting PHASE1

  2. Jul 2023 — Nov 2023 [monthly]

    Recruiting PHASE1

  3. Mar 2023 — Jul 2023 [monthly]

    Recruiting PHASE1

  4. Dec 2022 — Mar 2023 [monthly]

    Recruiting PHASE1

  5. Oct 2022 — Dec 2022 [monthly]

    Recruiting PHASE1

  6. Nov 2021 — Oct 2022 [monthly]

    Recruiting PHASE1

  7. Jan 2021 — Nov 2021 [monthly]

    Recruiting PHASE1

  8. Nov 2020 — Jan 2021 [monthly]

    Recruiting PHASE1

  9. May 2020 — Nov 2020 [monthly]

    Recruiting PHASE1

  10. Apr 2020 — May 2020 [monthly]

    Recruiting PHASE1

  11. Nov 2019 — Apr 2020 [monthly]

    Recruiting PHASE1

  12. Jun 2019 — Nov 2019 [monthly]

    Recruiting PHASE1

  13. Feb 2019 — Jun 2019 [monthly]

    Recruiting PHASE1

  14. Sep 2018 — Feb 2019 [monthly]

    Recruiting PHASE1

  15. Jun 2018 — Sep 2018 [monthly]

    Recruiting PHASE1

  16. Sep 2017 — Jun 2018 [monthly]

    Recruiting PHASE1

    First recorded

Jul 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Eisai Inc.
Data source: Eisai Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations